Immunostaining of post-mortem MS tissues also reveals GPR37-positive cells localized to peri-lesional areas, though overall expression appears diminished relative to non-lesioned white matter (Smith et al., 2017). The gene discussed is GPR37; the disease is myeloid sarcoma.